EGFR and lung carcinoma: Due to its ability to reverse poor PS and achieve the total regression of brain metastases, EGFR-TKI therapy may be a suitable treatment for brain metastasis in lung cancer with an EGFR mutation, particularly in elderly patients with poor PS.